Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Amedisys Inc (AMED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012221
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Amedisys Inc (Amedisys) is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort and support services for those are facing a terminal illness. It also provides speech pathology, social services for acute and chronic illnesses, private duty services and home health aide services. The company operates a network of medicare-certified home health care centers, and medicare-certified hospice care centers which cover across several states in the US and the District of Columbia. Amedisys is headquartered in Baton Rouge, Louisiana, the US.

Amedisys Inc (AMED) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amedisys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amedisys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Amedisys Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Amedisys Completes Acquisition Of Hospice Of Hackensack University Medical Center For US$4 Million 9
Asset Transactions 11
Amedisys Plans To Divest 35 Care Centers 11
Acquisition 12
Amedisys Completes The Acquisition Of Beacon Hospice 12
Amedisys Inc – Key Competitors 13
Amedisys Inc – Key Employees 14
Amedisys Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 18
Recent Developments 20
Financial Announcements 20
Nov 07, 2017: Amedisys Reports Third Quarter 2017 Financial Results 20
Oct 24, 2017: Amedisys Previews Strong Third Quarter 2017 Results 21
Jul 26, 2017: Amedisys Reports Second Quarter 2017 Financial Results 22
May 02, 2017: Amedisys Reports First Quarter 2017 Financial Results 23
Feb 28, 2017: Amedisys Reports Fourth Quarter and Year End 2016 Financial Results 24
Nov 03, 2016: Amedisys Reports Third Quarter Financial Results 25
Aug 02, 2016: Amedisys Reports Second Quarter Financial Results 26
May 03, 2016: Amedisys Reports First Quarter Financial Results 27
Mar 08, 2016: Amedisys Reports Fourth Quarter and Year End Financial Results 28
Corporate Communications 29
Oct 06, 2017: Scott Ginn Promoted to Chief Financial Officer at Amedisys 29
Jan 30, 2017: Amedisys Welcomes David Mikula as Chief Development Officer 30
Dec 20, 2016: Amedisys Welcomes Gary D. Willis as New Chief Financial Officer 31
Nov 04, 2016: Amedisys Brings In Christopher Gerard As New Chief Operating Officer 32
Apr 26, 2016: Amedisys Welcomes Three New Members To Its Board Of Directors 33
Other Significant Developments 34
Aug 17, 2017: Amedisys Clinical Programs Team Achieves National Readmissions Prevention Collaborative Certification 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Amedisys Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Amedisys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amedisys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amedisys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Amedisys Completes Acquisition Of Hospice Of Hackensack University Medical Center For US$4 Million 9
Amedisys Plans To Divest 35 Care Centers 11
Amedisys Completes The Acquisition Of Beacon Hospice 12
Amedisys Inc, Key Competitors 13
Amedisys Inc, Key Employees 14
Amedisys Inc, Subsidiaries 15
Amedisys Inc, Joint Venture 18

★調査レポート[Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析] (コード:DATA8012221)販売に関する免責事項を必ずご確認ください。
★調査レポート[Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆